Europe (WHO region) vs Saint Vincent and the Grenadines: New cases tested for RR-/MDR-TB
Europe (WHO region)
88.0%
in 2024
Saint Vincent and the Grenadines
100.0%
in 2023
Europe (WHO region) rank
3rd
Saint Vincent and the Grenadines rank
1st
New cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Saint Vincent and the Grenadines
How they compare
Saint Vincent and the Grenadines currently reports 100.0% against 88.0% in Europe (WHO region), a difference of 12.0%.
That makes Saint Vincent and the Grenadines's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 4 times across 13 shared years of data; in 2005 it was Saint Vincent and the Grenadines ahead.
Europe (WHO region) ranks 3rd and Saint Vincent and the Grenadines ranks 1st of 11 groups.
Across the 3 decades both report, Europe (WHO region) averaged higher in 2 and Saint Vincent and the Grenadines in 1.
Head to head by decade
| Decade | Europe (WHO region) | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.0% | 86.0% | 58.0% | Saint Vincent and the Grenadines |
| 2010s | 82.0% | 72.8% | 9.2% | Europe (WHO region) |
| 2020s | 91.5% | 75.0% | 16.5% | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Europe (WHO region) or Saint Vincent and the Grenadines?
- Saint Vincent and the Grenadines, at 100.0% against 88.0% in Europe (WHO region) as of 2023.
- What is the difference in new cases tested for rr-/mdr-tb between Europe (WHO region) and Saint Vincent and the Grenadines?
- 12.0%, with Saint Vincent and the Grenadines ahead.
- How many years of comparable data are there for Europe (WHO region) and Saint Vincent and the Grenadines?
- 13 years are reported by both, from 2005 to 2023.
- How do Europe (WHO region) and Saint Vincent and the Grenadines rank globally for new cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 3rd and Saint Vincent and the Grenadines ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.